Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cenicriviroc for HIV Associated Neurocognitive Disorder
NCT02128828Phase 2Completed
- Sponsor
- University of Hawaiʻi
- Start
- Apr 2014
- Primary completion
- Jun 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of cenicriviroc in HIV-associated neurocognitive disorder (HAND), sponsored by University of Hawaiʻi. Started Apr 2014; status: completed.
02
Drugs
cenicriviroc
03
Conditions
HIV-associated neurocognitive disorder (HAND)
Beyond the preview
Go deeper on NCT02128828.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02128828.